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ABSTRACT 
Lymphedema (LE) is a chronic medical condition characterized by lymphatic fluid retention, resulting in tissue 
swelling. There are two general classifications of LE; primary and secondary which are based on two mechanisms; 
lymphatic obstruction and lymphatic interruption. The most common cause of LE in the developing world is secondary 
to an infection known as filariasis. Cancer including Hodgkin and non-Hodgkin lymphomas; and its treatment are some 
causes of secondary LE. LE also could maintain the persistence of an occult localization of lymphoma. This case 
illustration describes a female, 57 year-old with stage II lymphedema of both legs, bilateral inguinal lymphadenopathies 
that were biopsied. The filarial blood examination was negative. Biopsies showed diffuse large B-cell lymphoma.  
Keyword: lymphedema, lymphoma.
ABSTRAK 
Limfedema (LE) adalah kondisi kronik berupa pembengkakan jaringan yang disebabkan retensi cairan limfatik. Ada dua 
klasifikasi umum LE, yaitu primer dan sekunder yang berdasarkan dua mekanisme; obstruksi limfatik dan gangguan 
limfatik. Penyebab LE paling umum di negara berkembang adalah sekunder, setelah infeksi filariasis. Berbagai jenis 
kanker, termasuk limfoma Hodgkin dan non-Hodgkin serta tata laksananya, juga merupakan penyebab LE sekunder. 
Limfadema juga dapat menjadi tempat persembunyian limfoma. Pada ilustrasi kasus ini, seorang perempuan berumur 
57 tahun dengan limfedema tingkat II pada kedua tungkai dan limfadenopati inguinal bilateral menjalani biopsi. 
Pemeriksaan darah filarial negatif dan hasil biopsi menunjukkan limfoma sel B besar difus.  
Kata Kunci: limfedema, limfoma.
INTRODUCTION 
Lymphedema (LE) is a chronic medical condition characterized by lymphatic fluid retention, resulting in tissue swelling. It is estimated that between 3 and 5 
million patients in the United States suffer from LE, with a significant proportion 
developing the disease as a consequence of cancer or its treatment. In oncology, 
the most common etiology for the development of LE is the impaired or disrupted 
flow of lymph fluid through the draining lymphatic vessels and lymph nodes, usually 
as a consequence of surgery and/or radiation therapy.
Cancer including Hodgkin and non-Hodgkin lymphomas; its treatment and other 
types of trauma are causes of secondary LE. Recurrent and metastatic malignancy; 
any treatments, whether surgical or irradiation; lymphadenectomy or surgical excision 
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of the inguinal, iliac, or auxiliary lymph nodes; and 
the most common non-infectious cause worldwide, 
especially following breast cancer treatment; 
nonsurgical trauma, e.g. radiation therapy to lymph 
node groups, surgery of the prostate, uterus, or 
cervix. Besides that, LE also could maintain the 
persistence of an occult localization of lymphoma, 
despite routine investigations found an apparent 
complete remission of disease
CASE ILLUSTRATION
 Female, 57 year-old came with a complaint 
of swollen both legs since one year ago. The swollen 
legs initially came and go, but later stayed. She 
had no other complaints such as pain, pallor, or 
erythema. Then she experienced enlargement of 
bilateral inguinal lymph node since 6 months ago, 
but with no pain, pallor, or erythema. Then the left 
inguinal lymph node became ulcerated. She had 
no decreased body weight, cough, palpitation, chest 
pain, nausea, vomit, or diarrhea. She had no history 
of diabetes, hypertension, cardiac disease, asthma 
or allergy. 
Her physical examination revealed within normal 
limit vital signs. Her general physical examination 
was also normal. Her legs were swollen, with non 
pitting edema, hyperkeratosis and hyperpigmentation, 
no pain, pallor or erythema. The circumference of 
the left femur was 77 centimeters and right femur 
was 72 centimeters. She also had bilateral inguinal 
lymphadenopathies with an ulcer in the left lymph 
node. Her laboratory results including hemostasis 
profile were within normal limits except lactate 
dehydrogenase (LDH) of 348 mg/dL. The filarial blood 
examination was negative. Computed tomography 
(CT) scan of the pelvic showed no mass. Biopsy 
done to the inguinal lymph node revealed that 
squamous epithelial cells, pleomorphic and hyper 
chromatic nucleated with coarse chromatin spreading 
to fibrous and muscle tissues, concluded as large 
B cell non Hodgkin lymphoma. 
The patient received a chemotherapy regimen of 
cyclophosphamide, vincristine and doxorubicin. The 
chemotherapy was done 6 cycles at an interval of 
3 weeks. The patient tolerated the protocol well 
and no complications occurred, but the lymphedema 
persisted.
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Picture 1. Lymphedema of left and right legs. The lymphedema affected the left leg to a greater extent compared to the right leg. There were 
non pitting edema, with skin changes such as hyperkeratosis and hyperpigmentation, no pain, pallor or erythema. There were bilateral inguinal 
lymphadenopathies with an ulcer in the left lymph node
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DISCUSSION
The development of LE occurs when the lymphatic 
load exceeds the transport capacity. There are two 
general classifications of LE; primary and secondary.1,2 
Primary LE develops as a consequence of a 
pathologic congenital and / or hereditary etiology. 
These various conditions include reduced numbers 
of lymphatic collectors and the decreased diameter 
of existing lymph vessels (hypoplasia); increased 
diameter of lymphatic collectors (hyperplasia); 
absence of lymphatic system components (aplasia); 
and inguinal lymph node fibrosis (Kinmonth 
syndrome).1-3 There are based on two basic 
mechanisms of secondary LE; lymphatic obstruction 
and lymphatic interruption.3 The most common 
cause of LE in the developing world is secondary 
to an infection by the nematode Wuscheria bancrofti, 
also known as filariasis.1,2 The most common cause 
of LE in the industrialized world is malignancy and 
malignancy-associated. Secondary LE can also be 
caused by surgery, radiation, trauma, infection, tumor 
blockage, chronic venous insufficiency, immobility, 
or tourniquet effects.3,4 Once damage has occurred 
to the lymphatic system, transport capacity is 
permanently diminished in the affected region, 
thereby predisposing that region to LE. Cancer, its 
treatment and other types of trauma are causes of 
secondary LE.3-6 Recurrent and metastatic malignancy; 
Hodgkin and non-Hodgkin lymphomas; any treatments, 
whether surgical or irradiation; lymphadenectomy 
or surgical excision of the inguinal, iliac, or auxiliary 
lymph nodes; and the most common non-infectious 
cause worldwide, especially following breast cancer 
treatment; nonsurgical trauma, e.g. radiation therapy 
to lymph node groups, surgery of the prostate, 
uterus, or cervix.3-5
The accumulation of lymph fluid in the interstitial 
may not be clinically evident in the early stages of 
the disease, but will occur if the lymphatic load 
increases above the reduced transport capacity of 
the lymphatic system. Therefore, a subclinical LE 
exists after surgery or radiation therapy, referred to 
as the latency stage or Stage 0. In this stage, there 
are no clinical signs of LE because the reduced 
transport capacity exceeds the lymphatic load of 
the tissues. Stage I lymphedema is referred to as 
reversible lymphedema. In this stage, the patient 
presents with very soft, pitting edema with no 
fibrosis. Prolonged elevation of the limb leads to 
complete resolution. Stage II lymphedema, also 
called spontaneously irreversible lymphedema, 
presents with intradermal fibrosis that decreases 
tissue suppleness and reduces the ability of the 
skin to indent with pressure. In this stage, resolution 
of clinically evident lymphedema is not possible 
with elevation. Stage III lymphedema is also called 
lymphostatic elephantiasis. It is associated with a 
significant increase in the severity of the fibrotic 
response, tissue volume, and other skin changes such 
as papillomas, cysts, fistulas, and hyperkeratosis. Skin 
folds on the wrists and ankles more deep. Recurrent 
bacterial and fungal infections of the skin and nails 
are more common in this stage. In Stage II and III 
the formation of adipose tissue is mainly responsible 
for the excess volume in swollen limbs that do not 
present with pitting. The comparative volumetric 
differences between the affected compared to the 
unaffected limb can be used as a supplement to 
further characterize the severity of each stage. Minimal 
severity represents a situation in which the affected 
limb has a measured volume that is less than 20% 
greater than the unaffected limb. A 20% to 40% 
difference represents moderate severity, and a 
difference of more than 40% is considered severe.1,4 
In the case of LE and lymphoma, a case study 
expressed that LE could maintain the persistence 
of an occult localization of lymphoma, despite routine 
investigations found an apparent complete remission 
of disease. The impaired lymphatic drainage area 
is like a safe place for the lymphoma cells to skip 
the anti proliferative effect of chemotherapy. In 
addition, the local immunodeficiency in the immune 
deficient district of LE might have promoted the 
chemotherapy resistance of malignant cells.6-8
The patient in the case illustration had stage II 
lymphedema, with lymphedema that was not 
reversible with elevation, decreased tissue suppleness 
and reduced ability of the skin to indent with 
pressure (non pitting).9,10 The skin also had 
hyperkeratosis and hyperpigmentation. Although 
the right leg seemed to be less in dimension to 
the left leg (72 vs. 77 centimeters), but it was not 
that the right leg was not affected. The lymphedema 
affected both legs, but with a greater extent to the 
left than the right leg. 
The lymphedema in this patient seemed to be 
secondary in nature, as the patient was 57 year-old, 
with no history of similar complaints in her life. 
The filariasis as a common etiology for lymphedema 
in this part of the world was negative, but the biopsy 
of the lymph node revealed lymphoma. Other 
etiologies of secondary lymphedema such as deep 
vein thrombosis or obstruction by a pelvic mass 
were negative. 
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In conclusion, the stage II lympedema of both 
legs of this patient was caused by bilateral inguinal 
lymphadenopathy, causing lymphatic obstruction. 
The large B cell lymphoma lymphadenopathy also 
caused lymphatic interruption. 
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